MAR vs PG: Which Is the Better Buy?
Side-by-side comparison of Marriott International, Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Marriott International, Inc. · Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction
Grade C
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
PG has more upside to fair value
(+10.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MAR |
PG |
| Current Price |
$366.24 |
$150.38 |
| Fair Value Estimate |
$353.64 |
$165.39 |
| Upside to Fair Value |
-3.4%
|
+10.0%
|
| Market Cap |
$96.6B |
$350.2B |
| Forward P/E |
—
|
21.5x
|
| EV / EBITDA |
23.8x
|
15.1x
|
| Price / Sales |
3.7x
|
4.0x
|
| Price / FCF |
31.6x
|
23.3x
|
| Revenue Growth YoY |
+6.2%
|
+7.4%
|
| Gross Margin |
21.4%
|
50.3%
|
| Operating Margin |
16.0%
|
23.2%
|
| Return on Equity |
-74.1%
|
31.3%
|
| Dividend Yield |
0.75% |
0% |
| FCF Yield |
3.17%
|
4.29%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
MAR |
PG |
| Zone Low |
$265.23 |
$124.04 |
| Zone High |
$300.59 |
$140.58 |
| In Buy Zone? |
No
|
No
|